NYSE:MD
Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc.'s revenue fell 4.9% in fiscal 2025 to $1.9B while operating margin rose to 10.9%. The diluted share count rose 2.3%.Summary generated from Pediatrix Medical Group, Inc.'s SEC filings. Latest annual report filed Feb 19, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$1.9B
Revenue growth−4.9%
Revenue, 5-yr CAGR+2.0%
Gross marginn/a
Operating margin10.9%
Net margin8.6%
ROIC14.3%
Return on equity20.3%
Debt / equity0.69
Free cash flown/a
FCF marginn/a
Share count change+2.3%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1,911 | 1,972 | 1,995 | 2,013 | 1,914 |
| Operating income | 203 | 173 | 7 | −69 | 209 |
| Net income | 131 | 66 | −60 | −99 | 165 |
| Free cash flow | n/a | n/a | n/a | n/a | n/a |
Recent filings
- 4Insider transaction report
Sep 14, 2026 - 4Insider transaction report
Aug 18, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 4, 2026 - 8-KResults of operations and financial condition
Aug 4, 2026 - 8-KDirector or officer change
Jul 24, 2026 - 8-KResults of operations and financial condition
Jul 15, 2026 - 8-KDirector or officer change
May 7, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 5, 2026